Skip to main content

Clinical Safety and Efficacy Testing

MD Lash Factor ® Eyelash Conditioner

Clinical Publication: Journal of Cosmetic and Laser Therapy (2008)
Medical Oversight: Bruce E. Kanengiser, M.D., Diplomate American Board of Ophthalmology
Safety Research: AppTec Laboratory Services & Clinical Research Laboratories, Inc.

Ocular & Systemic Safety Profile

  • Advanced Ocular Tolerance: Clinically evaluated for 0% potential for ophthalmic irritation. Testing specifically included subjects with sensitive eyes and contact lens wearers.
  • Physiological Integrity: Ophthalmic exams confirmed no changes in visual acuity, cornea health, or tear duct function.
  • Intraocular Pressure (IOP): Independent clinical trials showed no effect on IOP.
  • Toxicological Assays: Confirmed Non-Mutagenic (Ames Assay), Non-Cytotoxic (Agarose Overlay), and Non-Sensitizing (LLNA - Murine Local Lymph Node Assay).
EU Regulatory Safety Assessment (EC1223-2009):
Independent assessment conducted per Council Directive 76/768/EEC and Good Laboratory Practice (GLP) standards. Reviewer Dr. John Hopkins (BSc. PhD. MSB. C Biol.) evaluated:
  • Toxicological profiles and chemical structures of each ingredient.
  • Specific exposure characteristics for the intended application area.
  • Absence of prohibited, restricted, or improperly characterized substances.
Result: Deemed safe for sale and use in EU Countries.

MD® Brow

Clinical Site: Spincontrol North America Inc.
Lead Investigator: Patrick Beau, Ph.D.
  • Visible Density: 78% of study participants agreed their eyebrows appeared thicker after 56 days.
  • Health & Texture: 87% reported eyebrows appeared healthier and better hydrated; 78% noted improved conditioning.
  • High Tolerability: 87% of subjects confirmed the product did not irritate the eyes or skin.

MD® Hair Restoration & Nutri Hair

Clinical Site: Spincontrol North America Inc.
Bioavailability Testing: Independent Analytical Laboratory (Canada)

Hair Restoration System (Activator & Energizer)

  • Appearance of Growth: In a 17-week independent study, 71% of subjects observed a statistically significant improvement in the appearance of hair growth and density.
  • Subject Satisfaction: 75% recommendation rate among participants with chronic or acute hair loss.

MD Nutri Hair Supplements

  • Office-Based Review: 30-day observational review of 30 subjects confirmed high compliance and early improvements in hair strength and quality.
  • Bioavailability Confirmation: Independent analytical testing (using data-file response ratios and ISTD comparisons) verified the stability and bioavailability of core active ingredients, ensuring effective nutrient delivery.

MD® Scalp Essential

Clinical Site: Medcin Instituto da Pele
Standards: Good Clinical Practices (GCP) & Helsinki Declaration
  • Scalp Health: Demonstrated marked decrease in visible flaking and reduction in excess sebum (oil) production.
  • Irritation Relief: Significant clinical reduction in self-reported scalp itching and redness.
  • Dermatological Safety: 50-subject Repeat Insult Patch Test (RIPT) confirmed the product is hypoallergenic and non-sensitizing.

Clinical Summary Matrix

Product Primary Benefit Key Safety Milestone
MD Lash Factor Enhanced Lash Appearance Ophthalmologist Tested; Ames/LLNA Negative
MD Brow 78% Agree Brows Look Thicker Non-Irritating; Hydrating Formula
MD Hair System 71% Improve Growth Appearance 75% User Recommendation Rate
MD Scalp Essential Controls Flaking & Oil Hypoallergenic (RIPT Verified)
MD Nutri Hair Hair Quality & Strength Bioavailability Verified Active Ingredients

Regulatory Note: These findings are derived from independent clinical trials, toxicological assessments, and professional observational reviews. MD® products are cosmetic in nature and are intended to improve the appearance of the hair, lashes, and brows. They are not intended to diagnose, treat, cure, or prevent any medical condition or disease.

Powered by Omni Themes